|
|
The
Wilson laboratory combines an interest
in both membrane trafficking and signal
transduction, in normal and disease
cells.
Membrane Microdomains.
We use an
innovative electron microscopic approach
to follow the reorganization of plasma
membrane signaling components ---
including receptors, tyrosine kinases,
phosphopholipases and adaptor proteins
--- that occurs after activation. The
high spatial resolution provided by
electron microscopy is complemented by
live cell imaging approaches for
temporal resolution, in collaboration
with Dr. Diane Lidke, We
primarily focus on these classes of
receptors:
1.
Fc
receptors, particularly the high
affinity IgE receptor, FceRI
of mast cells and basophils. Various
aspects of FceRI receptor behavior -- including localization in “Protein Islands”,
confinement in cytoskeletal corrals and
internalization mechanisms -- are the
focus of NIAID-funded studies. In
addition, “crosstalk” between FceRI and other mast
cell/basophil receptors is a major focus
of the NIGMS-funded New Mexico
Spatiotemporal Modeling Center (Oliver,
PI).
2.
ErbB
family of receptors, particularly in the
context of breast and ovarian cancer
(UNM clinical partner, Dr. Carolyn
Muller). This work is aligned with the
Interagency Modeling and Analysis Group
initiative for multi-scale modeling. For
information on this program, go to
http://www.nibib.nih.gov/Research/MultiScaleModeling/IMAG.
3.
Receptors
and accessory molecules involved in
growth and survival of pre-B acute
lymphoblastic leukemia (UNM clinical
partner, Dr. Stuart Winter). This
project is supported by a
Leukemia/Lymphoma Society SCOR award to
a consortium of UNM investigators (Wilman,
PI; Wilson, Project PI).
Organization and Dynamics of Calcium
Stores.
We use a combination of high resolution
microscopy and mathematical modeling to
study calcium mobilization in the
context of cell geometry. See the
movies on this page for a demonstration
of some modeling results. Continuation
of this project is funded through the
NIGMS-funded New Mexico Spatiotemporal
Modeling Center.
Publications
(Partial list from over 70)
·
Wilson BS
, Deanin GG, Standefer JE, VanderJagt D,
Oliver JM. (1989) Depletion of guanine
nucleotides with mycophenolic acid
suppresses IgE-mediated degranulation in
rat basophilic leukemia cells. J.
Immunol. 143:259-265.
·
Wilson BS
, Palade GE, Farquhar MG. (1993) ER-to-Golgi
transport assay based on 0-glycosylation
of native glycophorin in permeabilized
erythroleukemia cells: Role for Gi3.
PNAS USA 90:1681-1685.
·
Wilson BS
, Komuro M, Farquhar MG. (1994) Cellular
variations in heterotrimeric G-protein
localization and expression in rat
pituitary. Endocrinology 134:233-244.
·
Wilson BS
, Meinkoth JL, McCaffery M, Nuoffer C,
Feramisco JR, Balch WE, Farquhar MG.
(1994) A Rab1 mutant affecting guanine
nucleotide exchange promotes disassembly
of the Golgi apparatus. J. Cell Biology
125:557-571.
·
Oliver JM,
Burg DL,
Wilson BS , McLaughlin
JL and Geahlen RL. (1994) Inhibition of
mast cell FceRI-mediated
signaling and effector function by the
Syk-selective inhibitor, piceatannol. J.
Biol. Chem. 269:29697-29703.
·
Wilson BS
, Kapp N, Lee RJ, Pfeiffer JR, Martinez
AM, Platt Y, Letourneur F and Oliver JM.
(1995) Distinct functions of the FceRI
g and
b
subunits in the control of FceRI-mediated
tyrosine kinase activation and signaling
responses in RBL-2H3 mast cells. J.
Biol. Chem. 270:4013-4022.
·
Barker S,
Caldwell K, Hall A, Martinez AM,
Pfeiffer JR, Oliver JM and
Wilson BS. (1995)
Wortmannin blocks lipid and protein
kinase activities associated with PI
3-kinase and inhibits a specific subset
of responses induced by FceRI
crosslinking. Mol. Biol. Cell 6:
1145-1158.
·
Barker
SA, Caldwell KK, Pfeiffer JR and
Wilson BS. (1998)
Wortmannin-sensitive phosphorylation,
translocation and activation of PLCg1,
but not PLCg2,
in antigen-stimulated RBL-2H3 mast
cells. Mol. Biol. Cell. 9: 483-496.
·
Wilson, BS
, Pfeiffer JR, Smith AJ, Oliver, JM,
Oberdorf, J, and Wojicikiewicz, RJH.
(1998) Calcium-dependent clustering of
inositol 1,4,5-trisphosphate receptors.
Mol. Biol. Cell. 9: 1465-1478.
·
Kepley
CL,
Wilson BS and Oliver JM.
(1998) Roles for the protein tyrosine
kinases Lyn, Syk and Zap-70 in FceRI-mediated
human basophil degranulation. J. Allergy
Clin. Immunol. 102:304-310.
·
Graham
TE, Pfeiffer JR, Lee RJ, Kusewitt DF,
Martinez AM, Foutz T,
Wilson BS and Oliver JM.
(1998) MEK/ERK activation in ras-disabled
RBL-2H3 mast cells and novel roles for
geranylgeranylated and farneyslated
proteins in FceR1-mediated
signalling. J. Immunol. 161:6733-6744.
·
Ortega EM,
Lara M, Lee, I, Santana C, Martinez AM,
Pfeiffer JR, Lee RJ,
WilsonBS and Oliver JM.
(1999) Lyn dissociation from
phosphorylated FceRI
subunits: a new regulatory step in the
FceR1
signaling cascade revealed by studies of
FceR1
dimer signaling activity. J. Immunol.
162:176-185.
·
Kepley
CL, Youssef L, Andrews RP,
Wilson BS and Oliver JM.
(1999) Syk deficiency in nonreleaser
basophils. J. Allergy Clin. Immunol.
104:279-284.
·
Wilson BS
, Pfeiffer JR and Oliver JM. (2000)
Observing FceRI
signalling from the inside of the mast
cell membrane. J. Cell Biology
149:1131-1142.
·
Kepley
CL, Cambier J, Lujan D, Ortega E, Morel
PA,
Wilson BS, Oliver JM.
(2000) Negative regulation of FceRI
: signaling by co-crosslinking to FceRII
in basophils. J. Allergy Clin Immunol.
106: 337-348.
·
Oliver JM,
Kepley CL, Ortega E and
Wilson BS. (2000)
Immunologically-mediated signaling in
basophils and mast cells: finding
therapeutic targets for allergic
diseases in the human FceRI
signaling pathway. Immunopharm.
48:269-281.
·
Kepley
CL, Youssef L, Andrews RP,
Wilson BS and Oliver JM.
(2000) Turning off IgE-mediated
signaling Nature’s way: reversible Syk
deficiency in non-releaser basophils.
Allergy Clinical Immunol. Intl. 12:11-17
·
Kepley
CL, Youssef L, Andrews RP,
Wilson BS , Oliver JM.
(2000) Multiple defects in FceRI-mediated
signaling in Syk-deficient nonreleaser
basophils & IL-3-induced recovery of Syk
expression & secretion. J. Immunol.
165:5913-5920.
·
Smith AJ,
Surviladze Z, Gaudet EA, Backer JM,
Mitchell CA,
Wilson BS. (2001) p110b
and p110d
PI-3 kinases upregulate upregulate FceRI-activated
Ca2+ influx by enhancing IP3
production. J. Biol. Chem.
276:17213-17220
·
Wilson, BS.
J.R. Pfeiffer, Z. Surviladze, E.A.
Gaudet and J.M. Oliver. (2001) High
resolution mapping reveals distinct FceRI
and LAT domains in activated mast cells.
J. Cell Biology 154:645-658.
·
Lara M,
Ortega E, Pecht I, Pfeiffer JR, Martinez
AM, Lee RJ, Surviladze Z,
Wilson BS, Oliver JM.
(2001) Overcoming the signaling defect
of Lyn-sequestering, signal-curtailing
FceRI
dimers. J. Immunol. 167:4329-4337.
·
Wilson BS
, Pfeiffer JR and Oliver JM. (2002) FceRI
signaling observed from the inside of
the mast cell membrane. Mol. Immunol.
38:1259-1268.
·
Smith AJ,
Pfeiffer JR, Zhang J, Martinez AM,
Griffiths GM and
Wilson BS. (2003)
Microtubule-dependent transport of
secretory vesicles in RBL-2H3 cells.
Traffic 4: 302-312.
·
Lam V,
Kalesnikoff J, Lee CWK, Hernandez-Hansen
V,
Wilson BS, Oliver JM
and Krystal G. (2003) IgE alone
stimulates mast cell adhesion to
fibronectin via pathways similar to
those used by IgE + antigen but distinct
from those used by Steel factor. Blood
102:1405-1413.
·
Wilson, BS
, SL Steinberg, K Liederman, JR
Pfeiffer, Z Surviladze, J Zhang, LE
Samelson, LH Yang, PG Kotula and JM
Oliver. (2004) Markers for
detergent-resistant lipid rafts occupy
distinct and dynamic domains in native
membranes. Mol. Biol Cell 15: 2580-2592.
·
Hernandez-Hansen, V, AJ Smith, Z
Surviladze, T Maizel, A Chigaev, J
Kalesnikoff, CA Lowell, LA Sklar, G
Krystal,
BS Wilson and JM Oliver.
(2004) Dysregulated FceRI
signaling and altered Fyn and SHIP
activities in Lyn-deficient mast cells.
J. Immunology 173: 100-112.
·
Valna P,
Ledbduska P, Draberova L, Henegerg P,
Boubelik M, V, Malissen M,
Wilson BS, Horejsi V and
Draber P. (2004) Negative regulatory
role of the non-T cell activation linker
in mast cell signaling. J. Exp.
Medicine. 200:1001-1013
·
Kim J-H,
L Cramer, H Mueller,
BS Wilson and B. Vilen.
(2005) Independent trafficking of Ig-a/b and mIg is facilitated by
dissociation of the BCR complex. J.
Immunology. 175: 147-154.
·
H
ernandez-Hansen,V, JDJ Bard, JA Wilder,
CA Lowell,
BS Wilson and JM Oliver.
(2005) Increased expression of genes
linked to FceRI
signaling and to chemokine and cytokine
production in Lyn-deficient mast cells.
J. Immunology. 175: 7880 - 7888.
·
Zhang, J,
K Leiderman, JR Pfeiffer,
BS Wilson, JM Oliver and
SL Steinberg. (2006) Characterizing the
topography of membrane receptors and
signaling molecules from spatial
patterns obtained using nanometer-scale
electron –dense probes and electron
microscopy. Micron 37:14-34.
·
D. J.
Frankel, J. Pfeiffer, J. M. Oliver,
BS Wilson and A. R.
Burns. (2006) Revealing the
topography of cellular membrane domains
by combined Atomic Force
Microscopy/fluorescence Imaging.
Biophysical J. 90: 2404-2413 (Cover).
·
Mean, S,
T Mazel, A Smith, J Shadid, J Shepard,
RJH Wojicikiewicz, G. Smith and
BS Wilson. (2006)
Reaction diffusion modeling of calcium
dynamics with realistic ER geometry.
Biophysical J. 91:537-557.
·
BF
Lillemeier, JR. Pfeiffer, Z Surviladze,
BS Wilson and MM Davis.
(2006) Plasma membrane-associated
proteins are clustered into islands
attached to the cytoskeleton.Proc.
Natl. Acad. Sci. USA 103: 18992-18997.
·
M Xue, G
Hsieh, M Raymond-Stintz, S Steinberg, E
Prossnitz , JM Oliver, D Lidke and
BS Wilson. (2007) FPR
and FceRI
occupy common domains for signaling and
internalization. Mol. Biol. Cell
18:1410-1420.
·
LA
Youssef, M Schuyler, L Gilmartin, G
Pickett, C Tarleton, T Archibeque, C
Qualles,
BS Wilson and JM Oliver.
(2007) “Non-releaser” and “cycler”
basophils occur in both control and
asthmatic subjects: distinct basal and
FceRI-activated
gene expression profiles in the
non-releaser and releaser phenotypes. J.
Immunology 178: 4584 - 4594.
·
Z
Surviladze, HA Harrison, RC Murphy and
BS Wilson. (2007) FceRI
and Thy-1 domains have unique protein
and lipid compositions. J. of Lipid
Research. 48: 1325-1335
·
BS Wilson,
JR Pfeiffer, M Raymond-Stintz, D Lidke,
K Lidke, N Andrews and JM Oliver. (2007)
Exploring membrane domains using native
membrane sheets and transmission
electron microscopy. Methods in
Molecular Biology, Lipid Rafts. T.
McIntosh, Ed. Humana Press 398:247-263.
·
S.Yang,
M.A. Raymond-Stintz, W. Ying, J. Zhang,
D.S. Lidke, S.L. Steinberg, L. Williams,
J.M. Oliver, B.S. Wilson. (2007)
Mapping ErbB receptors on breast cancer
cell membranes during signal
transduction. J. Cell Science 120:
2763-2773.
·
BA Stout, K. Melendez, JC Seagrave, MJ
Holtzman, B. Wilson, J Xiang, Y
Tesfagzi. (2007) STAT1 activation causes
translocation of Bax to the ER during
the resolution of airway mucous cell
hyperplasia by IFN-g.
J. Immunology 178:8107-8116.
·
L. Gilmartin, CA Tarleton, M Schuyler,
BS Wilson and J.M. Oliver (2008)
A Comparison of Inflammatory Mediators
Released by Basophils of Asthmatic and
Control Subjects in Response to High
Affinity IgE Receptor Aggregation.
Inter. Archives of Allergy & Immun.
145:182-192
·
J. Zhang, S.L. Steinberg, B.S. Wilson,
J.M. Oliver, L. R. Williams.
(2008) Markov Random Field modeling of
the spatial distribution of proteins on
cell membranes. Bulletin of
Mathematical Biology 70:297-321
·
JI Kashiwakura, S Xiao, J Kitaura, Y
Kawakami, M Maeda-Yamamoto, JR Pfeiffer,
BS Wilson, U Blank and T
Kawakami. (2008) IgE accelerates in
vitro development of mast cells and
modifies their phenotype. J. Leukocyte
Biol. In press. (Cover)
·
T Russell, JM Oliver, BS Wilson,
SS Winter and X Meng.
(2008) Ikaros splice variants in
monozygotic twins with MLL-rearranged
precursor-B acute lymphoblastic
leukemia. J. Pediatric Hem Onc
30:941-944.
·
NL Andrews, K Lidke, AR Burns, JM
Oliver, BS Wilson and D Lidke.
(2008) Actin restricts FceRI
diffusion and facilitates
antigen-induced receptor
immobilization. Nature Cell Biology
10:955-963.
·
Hsieh, W Shu, S Yang, M Raymond-Stintz,
D Vlahos, S Steinberg, BS Wilson*
and J Edwards. (2008) Stochastic
simulations of ErbB homo and hetero-dimerization:
potential impacts of receptor
conformational state and spatial
segregation. IET Systems Biology
2(5): 256-272. *
corresponding author
·
T Mazel, R Raymond, M Raymond-Stinz, S
Jett and BS Wilson. (2009)
Stochastic modeling of calcium in 3D
geometry. Biophysical Journal
96:1691-1706.
·
MN Costa, K Radhakrishnan, BS Wilson,
DG Vlachos and JS Edwards. (2009)
Coupled stochastic spatial and
non-spatial simulations of ErbB1
signaling pathways demonstrate the
importance of spatial organization in
signal transduction. PLoS One, in
press.
·
L Andrews, JR Pfeiffer, AM Martinez, DM
Haaland, RW Davis, T Kawakami, JM
Oliver, BS Wilson, DS Lidke.
Small, mobile FceRI
aggregates are signaling competent.
Immunity, in press.
·
M Oliver, CA Tarleton, L Gilmartin, T
Archigeque, CR Qualls, L Diehl, BS
Wilson, M Schuyler. (2009) Reduced
FceRI-mediated
release of asthma-promoting cytokines
and chemokines from human basophils
during Omalizumab therapy. Internat.
Archives Allergy Immunology, in
press.
|